Jones Financial Companies Lllp Blueprint Medicines Corp Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
A detailed history of Jones Financial Companies Lllp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Jones Financial Companies Lllp holds 69,232 shares of BPMC stock, worth $7.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,232Holding current value
$7.01 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
390Shares Held
68.6MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$673 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$672 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$548 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$390 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$311 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.04B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...